Abcellera Biologics Inc (ABCL) Stock Price, Quote & News

Company Profile

AbCellera Biologics Inc. engages in discovering and developing antibody-based medicines for indications with unmet medical need in the United States. Its lead product is ABCL635, an non-hormonal medicine, which is in Phase 2 clinical trial to treat moderate-to-severe vasomotor symptoms; and ABCL575, a fully human, half-life extended monoclonal antibody, which is in in a Phase 1 clinical trial for treating T-cell-mediated autoimmune conditions, such as atopic dermatitis. The company has a researc...

Industry: Biotechnology

Sector: Healthcare

Phone: 604 559 9005

Website: www.abcellera.com

Address:

150 W 4th Avenue, Vancouver, Canada

EchoAnalysis8 Mar. 19 at 8:46 AM

$ABCL let me be clear 👇 I will buy on a breakout from both moving averages and will buy again in subwave 2 Wave 5 target: +207% 🚀

0 · Reply

ProfitPills Mar. 18 at 8:31 PM

$TGTX $ABCL $FBIO $SNDK Trending now

0 · Reply

Biker68 Mar. 18 at 7:39 PM

$ABCL That's a pretty stupid comment on a day when oil surges and the whole tech sector is down.

0 · Reply

Brb579 Mar. 18 at 3:51 PM

$ABCL its dead

0 · Reply

tradersunion353 Mar. 18 at 2:20 PM

$ABCL Another disappointing performance for people who are invested here long term to make money Adding loading friends .. its golden opportunity for you all 🤣🤣🤣

0 · Reply

Rastafari Mar. 18 at 3:08 AM

$ABCL Good summary of today’s presentation: https://m.investing.com/news/transcripts/abcellera-at-keybanc-forum-strategic-advances-in-biotech-93CH-4567110?ampMode=1

0 · Reply

8008track Mar. 17 at 8:58 PM

$ABCL due to having internal GMP facility they don’t have to file patents right away. This allows them to file patents 2 or more years later. If you have a successful drug, then you get 2+ years of sales without any competition. This is potentially massive if they can get an approved drug.

1 · Reply

8008track Mar. 17 at 8:33 PM

$ABCL it’s go time

0 · Reply

UncleTomFlorida Mar. 17 at 4:11 PM

$ABCL https://x.com/um87777/status/2033917280514379793?s=20

0 · Reply

8008track Mar. 17 at 1:12 PM

$ABCL Anyone have a link to the live webcast? I'm looking for it and can't find it.

2 · Reply

AbCellera Biologics Inc. (ABCL) Presents at TD Cowen 46th Annual Health Care Conference Transcript

Feb 24, 2026, 7:27 PM EST - 22 days ago

AbCellera Biologics Inc. (ABCL) Q4 2025 Earnings Call Transcript

Feb 24, 2026, 4:05 PM EST - 22 days ago

AbCellera Reports Full Year 2025 Business Results

Feb 11, 2026, 4:05 PM EST - 5 weeks ago

AbCellera to Present at Upcoming Investor Conferences in March and April 2026

Jan 22, 2026, 4:05 PM EST - 7 weeks ago

AbCellera to Report Full Year 2025 Financial Results on February 24, 2026

Jan 14, 2026, 9:16 PM EST - 2 months ago

AbCellera Biologics Inc. (ABCL) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Jan 12, 2026, 9:00 AM EST - 2 months ago

AbCellera Announces First Patients Dosed in Phase 2 Portion of its Phase 1/2 Clinical Trial of ABCL635 for the Treatment of Vasomotor Symptoms Due to Menopause

Dec 18, 2025, 9:00 AM EST - 3 months ago

AbCellera and Bruker Reach Global Settlement of Patent Litigation

Dec 8, 2025, 4:05 PM EST - 3 months ago

AbCellera to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026

Dec 8, 2025, 1:37 PM EST - 3 months ago

AbCellera Biologics Inc. (ABCL) Presents at Piper Sandler 37th Annual Healthcare Conference Transcript

Nov 22, 2025, 12:23 AM EST - 4 months ago

AbCellera Biologics Inc. (ABCL) Presents at Jefferies London Healthcare Conference 2025 Transcript

Nov 10, 2025, 9:00 AM EST - 4 months ago

AbCellera Appoints Dr. Stephen Quake to its Board of Directors

Nov 7, 2025, 7:16 PM EST - 4 months ago

AbCellera Biologics Inc. (ABCL) Q3 2025 Earnings Call Transcript

Nov 6, 2025, 4:05 PM EST - 4 months ago

AbCellera Reports Q3 2025 Business Results

Oct 7, 2025, 4:05 PM EDT - 5 months ago

AbCellera to Participate at Upcoming Investor Conferences in November and December 2025

Oct 6, 2025, 7:35 AM EDT - 5 months ago

AbCellera Biologics: Entering Growth Phase After A Pause

Sep 29, 2025, 4:05 PM EDT - 6 months ago

AbCellera to Report Third Quarter 2025 Financial Results on November 6, 2025

Sep 10, 2025, 9:07 AM EDT - 6 months ago

AbCellera Appoints Dr. Sarah Noonberg as Chief Medical Officer

Aug 27, 2025, 9:00 AM EDT - 7 months ago

AbCellera Doses First Participants in a Phase 1 Clinical Trial of ABCL575

Aug 12, 2025, 4:05 PM EDT - 7 months ago

AbCellera to Participate at Upcoming Investor Conferences in September

Aug 7, 2025, 7:48 PM EDT - 7 months ago

AbCellera Biologics Inc. (ABCL) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:05 PM EDT - 7 months ago

AbCellera Reports Q2 2025 Business Results & First Participants Dosed in a Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms

Jul 7, 2025, 4:05 PM EDT - 9 months ago

AbCellera to Report Second Quarter 2025 Financial Results on August 7, 2025

May 30, 2025, 1:00 PM EDT - 10 months ago

AbCellera Receives Authorization from Health Canada to Initiate a Phase 1 Clinical Trial of ABCL575

May 14, 2025, 5:00 PM EDT - 11 months ago

AbCellera Receives Authorization from Health Canada to Initiate the Phase 1 Clinical Trial of ABCL635 for Vasomotor Symptoms Due to Menopause

May 12, 2025, 3:30 PM EDT - 11 months ago

AbCellera's Microfluidic Cell Culture Patent Affirmed Valid by the U.S. Court of Appeals for the Federal Circuit

May 9, 2025, 7:30 PM EDT - 11 months ago

AbCellera Presents Positive Preclinical Data on ABCL575 at the 2025 SID Annual Meeting

May 8, 2025, 10:33 PM EDT - 11 months ago

AbCellera Biologics Inc. (ABCL) Q1 2025 Earnings Call Transcript

May 8, 2025, 4:05 PM EDT - 11 months ago

AbCellera Reports Q1 2025 Business Results

Apr 29, 2025, 3:00 PM EDT - 11 months ago

AbCellera Presents Data Showing Preclinical Efficacy of PSMA x CD3 T-Cell Engagers at AACR 2025

Apr 8, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in May and June

Apr 3, 2025, 4:05 PM EDT - 1 year ago

AbCellera to Report First Quarter 2025 Financial Results on May 8, 2025

Mar 25, 2025, 4:30 PM EDT - 1 year ago

AbCellera Announces Presentation of In Vivo Data on PSMA x CD3 T-Cell Engagers at AACR 2025

Feb 27, 2025, 11:26 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q4 2024 Earnings Call Transcript

Feb 27, 2025, 4:05 PM EST - 1 year ago

AbCellera Reports Full Year 2024 Business Results

Feb 11, 2025, 4:05 PM EST - 1 year ago

AbCellera to Participate at Upcoming Investor Conferences in March

Jan 21, 2025, 4:05 PM EST - 1 year ago

AbCellera to Report Full Year 2024 Financial Results on February 27, 2025

Jan 13, 2025, 9:00 AM EST - 1 year ago

AbCellera Expands Collaboration with AbbVie to Develop Novel T-Cell Engagers for Oncology

Dec 23, 2024, 4:39 PM EST - 1 year ago

AbCellera Biologics: Still A Concept Stock

Nov 21, 2024, 4:05 PM EST - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in December and January

Nov 7, 2024, 10:05 AM EST - 1 year ago

AbCellera Presents Data on Applications of T-Cell Engager Platform at SITC 2024

Nov 4, 2024, 7:22 PM EST - 1 year ago

AbCellera Biologics Inc. (ABCL) Q3 2024 Earnings Call Transcript

Nov 4, 2024, 4:05 PM EST - 1 year ago

AbCellera Reports Q3 2024 Business Results

Oct 22, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in November 2024

Oct 14, 2024, 12:04 PM EDT - 1 year ago

AbCellera: A Platform To Pipeline Transition

Oct 4, 2024, 9:00 AM EDT - 1 year ago

AbCellera Announces Presentation on T-cell Engager Platform at the Society for Immunotherapy of Cancer (SITC) Annual Meeting 2024

Sep 26, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Report Third Quarter 2024 Financial Results on November 4, 2024

Aug 29, 2024, 4:05 PM EDT - 1 year ago

AbCellera to Present at Upcoming Investor Conferences in September

Aug 23, 2024, 4:43 AM EDT - 1 year ago

AbCellera: A Waiting Game With High Uncertainty

Aug 20, 2024, 9:45 AM EDT - 1 year ago

This Globant Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

GLOB AVDX LRN PGRU

EchoAnalysis8 Mar. 19 at 8:46 AM

$ABCL let me be clear 👇 I will buy on a breakout from both moving averages and will buy again in subwave 2 Wave 5 target: +207% 🚀

0 · Reply

ProfitPills Mar. 18 at 8:31 PM

$TGTX $ABCL $FBIO $SNDK Trending now

0 · Reply

Biker68 Mar. 18 at 7:39 PM

$ABCL That's a pretty stupid comment on a day when oil surges and the whole tech sector is down.

0 · Reply

Brb579 Mar. 18 at 3:51 PM

$ABCL its dead

0 · Reply

tradersunion353 Mar. 18 at 2:20 PM

$ABCL Another disappointing performance for people who are invested here long term to make money Adding loading friends .. its golden opportunity for you all 🤣🤣🤣

0 · Reply

Rastafari Mar. 18 at 3:08 AM

$ABCL Good summary of today’s presentation: https://m.investing.com/news/transcripts/abcellera-at-keybanc-forum-strategic-advances-in-biotech-93CH-4567110?ampMode=1

0 · Reply

8008track Mar. 17 at 8:58 PM

1 · Reply

8008track Mar. 17 at 8:33 PM

$ABCL it’s go time

0 · Reply

UncleTomFlorida Mar. 17 at 4:11 PM

$ABCL https://x.com/um87777/status/2033917280514379793?s=20

0 · Reply

8008track Mar. 17 at 1:12 PM

$ABCL Anyone have a link to the live webcast? I'm looking for it and can't find it.

2 · Reply

Thelonius_Stonk Mar. 16 at 10:40 PM

$ABCL looks aight

0 · Reply

tradersunion353 Mar. 16 at 10:33 PM

$ABCL Oh great — another round of posts celebrating the noble art of buying the dip. Apparently around 90% of the discussion has nothing to do with actual returns or the stock going up… just endless updates about adding, adding, and adding more. Truly refreshing content every single time. 🙃

1 · Reply

8008track Mar. 16 at 8:13 PM

$ABCL looking forward to the presentation/discussion tomorrow. 9am ET. https://investors.abcellera.com/events/event-details/2026/KeyBanc-Capital-Markets-Healthcare-Forum-2026-laAeXoqN7Y/default.aspx

0 · Reply

TheDrunkTrader69 Mar. 16 at 6:36 PM

$ABCL looks like its going to pop, I'm still buying so a dip is good for me

0 · Reply

Determinedstocks Mar. 16 at 5:03 PM

$ABCL Treading water... I need some big dips... April

0 · Reply

DragonAlgo Mar. 16 at 12:00 PM

🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-03-20 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $0.05 Stop: $0.04 TP1: $0.07 TP2: $0.09 TP3: $0.12 Active momentum environment. 🔗 https://dragonalgo.com

0 · Reply

8008track Mar. 15 at 8:51 PM

$ABCL when this explodes to the upside, it will be glorious.

0 · Reply

tradersunion353 Mar. 13 at 4:32 PM

$ABCL waiting for those adding and loading comments 🤣🤣🤣. Meanwhile stock performance.. you suck

0 · Reply

tkstockpicker Mar. 13 at 3:06 PM

$ABCL trimmed and banked 19% gain

0 · Reply

DragonAlgo Mar. 13 at 7:54 AM

🐉 $ABCL CALL — DragonAlgo® Signal Contract: ABCL CALL Expiry: 2026-04-17 | Strike: $4.00 | Type: CALL Option Plan (premium): Entry: $0.30 Stop: $0.22 TP1: $0.39 TP2: $0.51 TP3: $0.72 System-defined risk profile. 🔗 https://dragonalgo.com

0 · Reply

tradersunion353 Mar. 12 at 3:50 PM

$ABCL Adding… adding… and adding more 😂 Funny how people here get more excited when the stock drops than when it goes up.

1 · Reply

DeMampCamp Mar. 12 at 2:57 PM

$ABCL XBI getting hammered today, this is a nice day to accumulate some more!

0 · Reply

Market Cap	1.08B
Revenue (ttm)	75.13M
Net Income (ttm)	-146.41M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-194.88%
Debt to Equity Ratio	0.00

Volume	1,466,800
Avg Vol	4,266,230
Day's Range	N/A - N/A
Shares Out	303.16M
Stochastic %K	53%
Beta	0.84
Analysts	Strong Sell
Price Target	$8.43